March 2012 Blog Posts (5)

First-of-its-kind Clinical Study Explores Novel Non-Invasive Colon Cancer Screening Test

In a first-of-its-kind clinical trial, physician-scientists atUniversity Hospitals Case Medical Center's Seidman Cancer Center and Case Western Reserve University School of Medicine are studying a promising new non-invasive technology for colon cancer screening. The four-year study is recruiting patients to compare the effectiveness of stool DNA (SDNA) testing with colonoscopy for detecting large colon polyps.…

Continue

Added by Peter Hofland, PhD on March 30, 2012 at 10:30am — No Comments

Melanoma Drugs Receive Initial Positive Clinical Recommendation from pan-Canadian Oncology Drug Review

The Canadian regulatory body, pan-Canadian Oncology Drug Review or pCODR has made an initial recommendation that includes positive clinical evaluations for the treatment of metastatic melanoma, ipilimumab (Yervoy™, Bristol-Myers Squibb)and vemurafenib (Zelboraf®, Genentech). The drugs are…

Continue

Added by Peter Hofland, PhD on March 30, 2012 at 10:00am — No Comments

Study Shows a Bright Future for Antibody Cancer Therapy

Monoclonal Antibodies (mAbs), once touted as the "magic bullets" of cancer care, are now fulfilling that promise and more advances are on the way, say cancer researchers at the Georgetown Lombardi Comprehensive Cancer Center

In a review article posted online March 16 in Cell, the researchers say that refinements and modifications of monoclonal antibody drugs - several of which have already revolutionized the care of breast and colon cancer - are now being tested in…

Continue

Added by Editorial Team on March 15, 2012 at 2:30pm — No Comments

The Science of Genomics Helps Point to a New Approach to Faster Anticancer Drug Discovery

Tracking the genetic pathway of a disease offers a powerful, new approach to drug discovery, according to scientists at the University of California, San Diego School of Medicine who used the approach to uncover a potential treatment for prostate cancer, using a drug currently marketed for congestive heart failure. Their findings are published in the current…

Continue

Added by Peter Hofland, PhD on March 13, 2012 at 5:30pm — No Comments

Directly Injected Novel Viral Vector Designed Kill Brain Cancer Cells While Leaving Healthy Cells Unharmed

Researchers and surgeons working for the Univeristy of California San Diego Moores Cancer Center are among the first in the nation to treat patients with recurrent brain cancer by directly injecting an investigational viral vector into their tumor. The treatment is being developed by a local San Diego Company, Tocagen Inc. 

 

The Toca 511 (vocimagene amiretrorepvec) virus replicates by budding and spreads…

Continue

Added by Peter Hofland, PhD on March 1, 2012 at 6:00pm — No Comments

Monthly Archives

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2005

2004

2001

Register for free to view all the Onco'Zine - The International Oncology Network content:

ADVERTISEMENT/MEDIA PARTNER

Onco'Zine is present here

Bookmark / Share

CONNECT WITH US AND

JOIN THE CONVERSATION


© 2017   Created by Peter Hofland, PhD.   Powered by

Badges  |  Report an Issue  |  Terms of Service

Find us on Google+